There are 59 papers on left ventricular diastolic dysfunction in aging research: 4 trials and 39 observational studies in people, 7 in animals, 10 reviews. The newest story, Nov 7, 2026: “Lung artery pressure kept rising into very late life”.
Left ventricular diastolic dysfunction is linked with older age in people with preserved ejection fraction and frailty in elderly inpatients with normal ejection fraction. Human cohorts also link it with obesity and subsequent cardiovascular events in people with preserved ejection fraction. A trial in people with type 2 diabetes and diastolic dysfunction shows no clear effect of coenzyme Q10 or fenofibrate.
42 findings in 29 papers from 2008 to 2026, 12 of them since April 2026
“Prevalence was higher in hypertension (13.1%, 95% CI: 11.4-15.0)”
Coenzyme Q10 showed no clear effect on left ventricular diastolic dysfunction in type 2 diabetic subjects with left ventricular diastolic dysfunction (P > 0.05).
“Neither fenofibrate nor CoQ, alone or in combination, altered early diastolic mitral annular myocardial relaxation velocity (E')”
Human trialin type 2 diabetic subjects with left ventricular diastolic dysfunction200 mg daily6 months
Fenofibrate showed no clear effect on left ventricular diastolic dysfunction in type 2 diabetic subjects with left ventricular diastolic dysfunction (P > 0.05).
“Neither fenofibrate nor CoQ, alone or in combination, altered early diastolic mitral annular myocardial relaxation velocity (E')”
Human trialin type 2 diabetic subjects with left ventricular diastolic dysfunction160 mg daily6 months
Inflammation induces left ventricular diastolic dysfunction in humans (obesity-associated low-grade systemic inflammation).
“Obesity-associated low-grade systemic inflammation may induce/heighten inflammatory activation of the coronary microvascular endothelium, leading to cardiomyocyte hypertrophy/ stiffness, myocardial fibrosis, and left ventricular diastolic dysfunction.”
Age is linked with a higher risk of left ventricular diastolic dysfunction in humans (preserved left ventricular ejection fraction) (adjusted OR 1.11, 95% CI 1.07 to 1.15).
“Multivariate logistic regression analysis demonstrated that older age (adjusted odds ratio [OR], 1.11; 95% confidence interval [CI], 1.07 to 1.15) and lower SVR (adjusted OR, 0.08; 95% CI, 0.01 to 0.57) were independent risk factors for LVDD.”
Humanspreserved left ventricular ejection fractionn = 1,070
Hypertension research : official journal of the Japanese Society of Hypertension·
Epicardial adipose tissue thickness
↑upin humans2OR 1.2
2 studies
Epicardial adipose tissue thickness is associated with left ventricular diastolic dysfunction in humans (multivariable analysis; LVDD ≥ Grade I) (OR 1.20 per 1 mm; 95% CI 1.08–1.34).
“EAT thickness (odds ratio [OR] = 1.20 per 1 mm; 95% confidence interval [CI] 1.08-1.34)”
Obesity is associated with left ventricular diastolic dysfunction in humans (obese participants compared with normal-weight controls) (LVDD prevalence 45% vs. 15%, p < 0.001).
“The prevalence of LVDD was significantly higher in obese individuals than in controls (45% vs. 15%, p < 0.001).”
Humansobese participants compared with normal-weight controlsleft ventriclen = 240
Obesity is associated with left ventricular diastolic dysfunction in humans (obese vs normal-weight controls) (58.3% vs 20.9%, p<0.001).
“Obese participants had greater EAT thickness (6.2±1.1 vs 4.0±0.9 mm), higher E/e′ (9.8±2.1 vs 8.1±1.9), larger LAVI (31±6 vs 26±5 mL/m2), and higher LVDD prevalence (58.3% vs 20.9%) than controls (all p<0.001).”
Perfused boundary region predicts left ventricular diastolic dysfunction in humans.
“Greater EG barrier impairment, non-invasively quantified by sublingual PBR, is independently associated with both the presence and longitudinal progression of ALVDD in an elderly Chinese population.”
PREVENT-HF is associated with left ventricular diastolic dysfunction in humans (model incorporating plaque area and PREVENT-HF) (OR per SD, 2.60; 95% CI, 1.30-5.20; P=.007).
“PREVENT-HF was independently associated with diastolic dysfunction (OR per SD, 2.60; 95% CI, 1.30-5.20; P=.007), whereas plaque area was not.”
Humansmodel incorporating plaque area and PREVENT-HFleft ventriclen = 70
Smoking is associated with left ventricular diastolic dysfunction in humans (patients with rheumatoid arthritis; history of smoking; multivariate logistic regression).
“increasing age (p<0.01) and history of smoking (p=0.04) were independently associated with LVDD.”
Humanspatients with rheumatoid arthritis; history of smoking; multivariate logistic regressionleft ventriclen = 83
Basal inferior longitudinal strain is associated with left ventricular diastolic dysfunction in humans (exploratory analysis; per 1 percentage-point shift toward less negative strain) (OR 1.13 per 1 percentage-point shift toward less negative strain, 95% CI 1.01–1.26; p = 0.038).
“Basal inferior strain was associated with LV diastolic dysfunction (OR 1.13 per 1 percentage-point shift toward less negative strain, 95% CI 1.01–1.26; p = 0.038).”
Humansexploratory analysis; per 1 percentage-point shift toward less negative strainleft ventriclefemalesn = 153
Human studies associate perfused boundary region with left ventricular diastolic dysfunction and report prediction over 23 months. In diabetic patients without known heart disease, peak filling rate and time to peak filling rate predict dysfunction, while myocardial ischemia is associated with it. Dysfunction also increases artery age gap in humans.
In 479 older adults followed for 12.5 years, average lung artery pressure rose by 8 millimeters of mercury from its starting level.In 479 older adults followed for 12.5 years, average lung artery pressure rose by 8 millimeters of mercury from its starting level.
A 36-year cohort study of 1,948 people linked higher cumulative body mass index and greater variability to more severe heart, kidney and metabolic problems.A 36-year cohort study of 1,948 people linked higher cumulative body mass index and greater variability to more severe heart, kidney and metabolic problems.
Who was studied1,948 people followed from childhood to midlife, 36 years
What changedAdvanced heart, kidney and metabolic problems were more common with higher cumulative body mass index (odds ratio 2.18 per standard-deviation increase)
The catchBMI variability relied on eight measurements over 36 years, potentially missing fluctuations between visits